Beyond ex vivo and in vivo CAR T: antigen-driven CAR T (adCAR-T) expansion method enables rapid, physiological CAR T cells programming.
This paper introduces adCAR-T, an antigen-driven CAR T-cell expansion method that enables rapid, physiological CAR T cell programming without ex vivo manufacturing or lymphodepleting chemotherapy.
bioRxiv · May 18, 2026 · PreprintImmunology